This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
chronic | hepatitis | 825 |
- | cell | 803 |
immune | response | 630 |
- | time | 613 |
red | blood | 573 |
red | cell | 473 |
antiviral | activity | 446 |
immune | responses | 418 |
viral | rna | 375 |
viral | infections | 353 |
- | hcv | 332 |
viral | infection | 324 |
red | cells | 304 |
- | cells | 276 |
viral | proteins | 271 |
- | transfusion | 237 |
chronic | hcv | 216 |
- | infection | 196 |
- | rna | 194 |
- | c | 175 |
first | time | 167 |
viral | protein | 162 |
- | treatment | 140 |
viral | hepatitis | 138 |
high | levels | 126 |
specific | antibodies | 125 |
positive | samples | 119 |
high | level | 115 |
positive | results | 108 |
- | protein | 102 |
chronic | infection | 102 |
several | studies | 100 |
positive | patients | 98 |
- | level | 90 |
antiviral | effects | 86 |
acute | hepatitis | 85 |
immune | cells | 83 |
other | viruses | 82 |
positive | cells | 81 |
human | cells | 80 |
antiviral | effect | 78 |
clinical | studies | 78 |
other | studies | 78 |
antiviral | response | 77 |
- | expression | 70 |
cellular | proteins | 69 |
viral | diseases | 68 |
positive | donors | 66 |
low | levels | 65 |
- | blood | 65 |
antiviral | activities | 63 |
higher | levels | 61 |
- | antibodies | 59 |
- | donor | 57 |
negative | blood | 57 |
negative | patients | 57 |
antiviral | treatment | 54 |
positive | result | 54 |
similar | results | 54 |
significant | effect | 50 |
- | virus | 50 |
low | level | 49 |
- | day | 47 |
different | hcv | 47 |
viral | response | 47 |
- | hepatitis | 46 |
chronic | disease | 46 |
positive | antibody | 46 |
significant | antibodies | 46 |
specific | antibody | 46 |
many | viruses | 44 |
antiviral | responses | 44 |
clinical | response | 44 |
other | groups | 43 |
single | donor | 43 |
- | activity | 42 |
- | antibody | 42 |
clinical | samples | 42 |
- | response | 40 |
different | cell | 40 |
acute | hcv | 39 |
human | hepatitis | 39 |
other | blood | 38 |
clinical | study | 37 |
lower | levels | 37 |
acute | infection | 36 |
many | patients | 36 |
negative | results | 36 |
positive | blood | 36 |
different | blood | 34 |
new | donors | 34 |
many | studies | 33 |
viral | disease | 33 |
- | patients | 33 |
- | donors | 33 |
many | cases | 31 |
- | effects | 31 |
different | viruses | 31 |
human | blood | 30 |
different | time | 30 |
human | viruses | 29 |
negative | samples | 29 |
other | infections | 29 |
different | methods | 28 |
several | viruses | 28 |
cellular | protein | 28 |
human | infection | 27 |
new | blood | 27 |
specific | responses | 27 |
other | patients | 26 |
first | case | 25 |
immune | cell | 25 |
other | diseases | 25 |
negative | result | 24 |
negative | effects | 24 |
high | expression | 24 |
first | study | 24 |
different | levels | 24 |
- | group | 23 |
chronic | infections | 23 |
different | groups | 23 |
other | hcv | 23 |
other | proteins | 23 |
positive | cases | 23 |
positive | effect | 23 |
other | rna | 22 |
several | days | 21 |
single | cell | 21 |
such | studies | 21 |
anti | hcv | 20 |
first | transfusion | 20 |
high | blood | 20 |
human | diseases | 20 |
new | cases | 20 |
new | method | 20 |
similar | studies | 19 |
specific | virus | 19 |
negative | donors | 19 |
- | patient | 19 |
human | infections | 19 |
cellular | rna | 18 |
first | group | 18 |
new | hcv | 18 |
other | methods | 18 |
several | cases | 18 |
such | patients | 18 |
lower | level | 17 |
specific | rna | 17 |
specific | cell | 17 |
positive | group | 17 |
highest | level | 17 |
low | blood | 17 |
human | disease | 17 |
chronic | diseases | 17 |
cellular | response | 16 |
viral | activity | 15 |
specific | group | 15 |
negative | group | 15 |
higher | expression | 15 |
first | results | 15 |
clinical | effect | 15 |
- | effect | 15 |
first | blood | 15 |
other | cell | 14 |
several | groups | 14 |
other | patient | 14 |
viral | levels | 14 |
many | blood | 14 |
different | response | 14 |
clinical | transfusion | 14 |
- | sample | 14 |
- | studied | 13 |
higher | level | 13 |
immune | antibodies | 13 |
other | day | 13 |
positive | donor | 13 |
several | methods | 13 |
specific | blood | 13 |
specific | case | 13 |
such | cases | 13 |
several | proteins | 12 |
negative | effect | 12 |
similar | levels | 12 |
several | hcv | 12 |
new | infections | 12 |
large | blood | 12 |
first | patient | 12 |
different | studies | 12 |
clinical | disease | 12 |
clinical | cases | 12 |
new | hepatitis | 11 |
several | rna | 11 |
several | diseases | 11 |
positive | hcv | 11 |
new | treatment | 11 |
more | studies | 11 |
different | times | 11 |
acute | infections | 11 |
- | infections | 11 |
- | groups | 11 |
other | virus | 10 |
specific | response | 10 |
specific | activity | 10 |
similar | hcv | 10 |
significant | antibody | 10 |
several | times | 10 |
several | cell | 10 |
negative | antibody | 10 |
other | cases | 10 |
new | methods | 10 |
more | time | 10 |
more | patients | 10 |
human | cell | 10 |
different | treatment | 10 |
larger | study | 9 |
specific | proteins | 9 |
specific | cells | 9 |
single | sample | 9 |
similar | study | 9 |
other | treatments | 9 |
other | cells | 9 |
many | rna | 9 |
many | groups | 9 |
- | case | 9 |
large | study | 9 |
different | virus | 9 |
different | diseases | 9 |
clinical | hepatitis | 9 |
chronic | patients | 9 |
cellular | blood | 9 |
antiviral | treatments | 9 |
first | cases | 9 |
positive | effects | 8 |
new | viruses | 8 |
other | antibodies | 8 |
other | disease | 8 |
other | donors | 8 |
significant | levels | 8 |
positive | patient | 8 |
positive | sample | 8 |
several | samples | 8 |
new | donor | 8 |
new | virus | 8 |
different | patient | 8 |
more | viruses | 8 |
higher | hcv | 8 |
antiviral | protein | 8 |
acute | disease | 8 |
high | hcv | 8 |
cellular | responses | 8 |
human | protein | 8 |
human | studies | 8 |
human | virus | 8 |
large | group | 8 |
many | diseases | 8 |
high | cell | 7 |
viral | effects | 7 |
such | cells | 7 |
specific | expression | 7 |
new | patients | 7 |
low | rna | 7 |
low | hcv | 7 |
low | expression | 7 |
first | hcv | 7 |
different | proteins | 7 |
different | cells | 7 |
clinical | results | 7 |
chronic | antibody | 7 |
- | times | 7 |
- | disease | 7 |
first | day | 7 |
single | treatment | 6 |
other | activities | 6 |
other | samples | 6 |
similar | result | 6 |
single | blood | 6 |
single | protein | 6 |
such | infections | 6 |
specific | hcv | 6 |
specific | protein | 6 |
specific | treatment | 6 |
such | treatment | 6 |
viral | cell | 6 |
more | days | 6 |
new | antibodies | 6 |
different | donors | 6 |
many | donors | 6 |
clinical | effects | 6 |
larger | studies | 6 |
acute | virus | 6 |
cellular | level | 6 |
chronic | treatment | 6 |
clinical | case | 6 |
antiviral | proteins | 6 |
- | levels | 6 |
high | antibody | 6 |
higher | donor | 6 |
highest | activity | 6 |
important | blood | 6 |
large | sample | 6 |
similar | level | 5 |
negative | cases | 5 |
negative | donor | 5 |
negative | hcv | 5 |
new | cell | 5 |
new | treatments | 5 |
several | patients | 5 |
significant | blood | 5 |
significant | effects | 5 |
similar | effect | 5 |
specific | viruses | 5 |
single | case | 5 |
specific | disease | 5 |
specific | effect | 5 |
specific | groups | 5 |
specific | results | 5 |
more | donor | 5 |
such | antibodies | 5 |
such | transfusions | 5 |
viral | effect | 5 |
viral | responses | 5 |
more | donors | 5 |
other | group | 5 |
many | cell | 5 |
different | effects | 5 |
low | response | 5 |
- | days | 5 |
- | responses | 5 |
- | result | 5 |
- | study | 5 |
cellular | hcv | 5 |
chronic | blood | 5 |
chronic | transfusion | 5 |
clinical | patients | 5 |
cellular | activity | 5 |
different | expression | 5 |
first | days | 5 |
first | result | 5 |
higher | antibody | 5 |
higher | response | 5 |
highest | expression | 5 |
human | antibody | 5 |
immune | diseases | 5 |
different | sample | 5 |
low | antibody | 5 |
several | levels | 4 |
significant | response | 4 |
significant | level | 4 |
significant | infection | 4 |
significant | disease | 4 |
several | virus | 4 |
other | hepatitis | 4 |
positive | rna | 4 |
other | transfusion | 4 |
new | level | 4 |
non | response | 4 |
similar | effects | 4 |
significant | transfusion | 4 |
such | donors | 4 |
similar | expression | 4 |
similar | patient | 4 |
similar | responses | 4 |
single | cells | 4 |
single | donors | 4 |
single | virus | 4 |
specific | cases | 4 |
specific | effects | 4 |
specific | transfusion | 4 |
such | diseases | 4 |
such | results | 4 |
viral | treatment | 4 |
new | rna | 4 |
other | study | 4 |
new | antibody | 4 |
high | virus | 4 |
negative | patient | 4 |
acute | blood | 4 |
acute | response | 4 |
cellular | expression | 4 |
chronic | transfusions | 4 |
clinical | treatment | 4 |
different | group | 4 |
different | results | 4 |
different | rna | 4 |
first | treatment | 4 |
high | activity | 4 |
high | sample | 4 |
different | activities | 4 |
highest | levels | 4 |
lower | response | 4 |
human | cases | 4 |
negative | disease | 4 |
negative | cell | 4 |
more | transfusions | 4 |
more | infections | 4 |
more | samples | 4 |
large | studies | 4 |
important | viruses | 4 |
human | samples | 4 |
human | proteins | 4 |
human | hcv | 4 |
other | protein | 3 |
more | times | 3 |
other | effects | 3 |
other | case | 3 |
non | hcv | 3 |
negative | studied | 3 |
negative | hepatitis | 3 |
negative | cells | 3 |
lower | day | 3 |
more | blood | 3 |
many | proteins | 3 |
many | methods | 3 |
lowest | level | 3 |
lower | expression | 3 |
lower | blood | 3 |
other | treatment | 3 |
other | sample | 3 |
specific | time | 3 |
others | donors | 3 |
single | antibody | 3 |
viral | activities | 3 |
specific | treatments | 3 |
low | sample | 3 |
specific | patient | 3 |
specific | infection | 3 |
single | patient | 3 |
similar | method | 3 |
positive | expression | 3 |
similar | activity | 3 |
several | transfusion | 3 |
several | case | 3 |
positive | transfusions | 3 |
positive | infection | 3 |
positive | hepatitis | 3 |
lower | antibody | 3 |
more | patient | 3 |
low | cells | 3 |
first | sample | 3 |
different | hepatitis | 3 |
different | effect | 3 |
different | disease | 3 |
clinical | expression | 3 |
clinical | blood | 3 |
chronic | virus | 3 |
chronic | treatments | 3 |
cellular | activities | 3 |
antiviral | rna | 3 |
antiviral | antibody | 3 |
antiviral | antibodies | 3 |
- | viruses | 3 |
- | treatments | 3 |
- | proteins | 3 |
larger | samples | 3 |
different | samples | 3 |
cellular | levels | 3 |
first | studies | 3 |
immune | effects | 3 |
larger | patient | 3 |
high | donor | 3 |
larger | groups | 3 |
large | rna | 3 |
large | donor | 3 |
important | cell | 3 |
important | protein | 3 |
high | rna | 3 |
human | rna | 3 |
human | antibodies | 3 |
higher | patient | 3 |
high | treatment | 3 |
human | study | 3 |
high | transfusion | 3 |
significant | activity | 2 |
positive | response | 2 |
positive | responses | 2 |
positive | transfusion | 2 |
several | time | 2 |
several | cells | 2 |
several | protein | 2 |
others | infections | 2 |
several | treatment | 2 |
positive | infections | 2 |
new | group | 2 |
other | times | 2 |
other | method | 2 |
other | donor | 2 |
new | study | 2 |
new | proteins | 2 |
new | infection | 2 |
negative | sample | 2 |
negative | infection | 2 |
negative | groups | 2 |
similar | time | 2 |
similar | antibody | 2 |
such | virus | 2 |
similar | viruses | 2 |
single | cases | 2 |
more | results | 2 |
viral | studies | 2 |
viral | sample | 2 |
viral | level | 2 |
viral | c | 2 |
such | responses | 2 |
such | response | 2 |
such | proteins | 2 |
such | method | 2 |
such | effects | 2 |
such | blood | 2 |
such | activities | 2 |
specific | patients | 2 |
specific | level | 2 |
specific | infections | 2 |
single | treatments | 2 |
single | time | 2 |
single | rna | 2 |
single | day | 2 |
more | virus | 2 |
lowest | levels | 2 |
more | cell | 2 |
clinical | sample | 2 |
first | donor | 2 |
first | cell | 2 |
first | antibody | 2 |
different | patients | 2 |
different | level | 2 |
different | donor | 2 |
different | days | 2 |
different | antibody | 2 |
different | antibodies | 2 |
clinical | infection | 2 |
high | case | 2 |
clinical | activity | 2 |
cellular | effects | 2 |
antiviral | studies | 2 |
antiviral | methods | 2 |
acute | patients | 2 |
acute | cell | 2 |
acute | cases | 2 |
- | results | 2 |
many | virus | 2 |
first | studied | 2 |
- | methods | 2 |
high | cells | 2 |
important | treatment | 2 |
high | protein | 2 |
lower | transfusion | 2 |
lower | hcv | 2 |
lower | cell | 2 |
lower | activity | 2 |
low | activity | 2 |
larger | viruses | 2 |
larger | sample | 2 |
large | virus | 2 |
largest | study | 2 |
important | effects | 2 |
human | patients | 2 |
high | response | 2 |
human | donors | 2 |
human | donor | 2 |
highest | virus | 2 |
highest | response | 2 |
higher | cell | 2 |
important | diseases | 2 |
new | sample | 1 |
newer | hcv | 1 |
new | transfusion | 1 |
new | studies | 1 |
low | virus | 1 |
new | patient | 1 |
new | groups | 1 |
new | expression | 1 |
other | days | 1 |
newer | treatment | 1 |
several | disease | 1 |
other | results | 1 |
other | studied | 1 |
others | patients | 1 |
positive | case | 1 |
positive | cell | 1 |
positive | disease | 1 |
positive | groups | 1 |
positive | viruses | 1 |
several | antibody | 1 |
new | activity | 1 |
several | donor | 1 |
new | cells | 1 |
more | antibodies | 1 |
negative | treatment | 1 |
many | infections | 1 |
lower | % | 1 |
several | effects | 1 |
lower | case | 1 |
lower | protein | 1 |
lower | treatment | 1 |
lower | virus | 1 |
many | activities | 1 |
many | antibodies | 1 |
many | cells | 1 |
many | protein | 1 |
negative | rna | 1 |
many | results | 1 |
many | sample | 1 |
more | cases | 1 |
more | groups | 1 |
more | proteins | 1 |
more | studied | 1 |
more | transfusion | 1 |
negative | case | 1 |
negative | response | 1 |
several | donors | 1 |
single | proteins | 1 |
several | infections | 1 |
such | methods | 1 |
specific | diseases | 1 |
specific | hepatitis | 1 |
specific | method | 1 |
specific | methods | 1 |
specific | studies | 1 |
such | activity | 1 |
such | hcv | 1 |
such | hepatitis | 1 |
such | infection | 1 |
such | protein | 1 |
single | viruses | 1 |
such | study | 1 |
such | transfusion | 1 |
such | viruses | 1 |
viral | antibodies | 1 |
viral | antibody | 1 |
viral | expression | 1 |
viral | group | 1 |
viral | samples | 1 |
low | protein | 1 |
specific | day | 1 |
single | transfusion | 1 |
several | patient | 1 |
similar | activities | 1 |
significant | cell | 1 |
significant | expression | 1 |
significant | hcv | 1 |
significant | responses | 1 |
significant | result | 1 |
significant | results | 1 |
significant | time | 1 |
significant | treatment | 1 |
similar | % | 1 |
similar | blood | 1 |
single | study | 1 |
similar | case | 1 |
similar | cell | 1 |
similar | response | 1 |
similar | treatment | 1 |
single | group | 1 |
single | hcv | 1 |
single | method | 1 |
single | patients | 1 |
single | responses | 1 |
low | results | 1 |
- | cases | 1 |
low | patients | 1 |
low | patient | 1 |
clinical | diseases | 1 |
clinical | groups | 1 |
clinical | level | 1 |
clinical | responses | 1 |
clinical | treatments | 1 |
clinical | virus | 1 |
different | protein | 1 |
different | responses | 1 |
different | result | 1 |
different | study | 1 |
different | transfusion | 1 |
different | treatments | 1 |
first | disease | 1 |
first | hepatitis | 1 |
first | infection | 1 |
first | level | 1 |
first | method | 1 |
first | protein | 1 |
first | resulted | 1 |
first | virus | 1 |
high | infection | 1 |
chronic | studies | 1 |
chronic | group | 1 |
chronic | expression | 1 |
acute | study | 1 |
- | activities | 1 |
- | diseased | 1 |
- | diseases | 1 |
- | expressions | 1 |
- | grouping | 1 |
- | method | 1 |
- | samples | 1 |
- | studies | 1 |
acute | diseases | 1 |
acute | transfusion | 1 |
chronic | effects | 1 |
acute | treatment | 1 |
acute | viruses | 1 |
anti | hepatitis | 1 |
antiviral | infection | 1 |
antiviral | infections | 1 |
antiviral | study | 1 |
antivirals | effects | 1 |
cellular | treatment | 1 |
chronic | cases | 1 |
high | patient | 1 |
higher | % | 1 |
higher | activity | 1 |
larger | protein | 1 |
large | % | 1 |
large | case | 1 |
large | effect | 1 |
large | groups | 1 |
large | protein | 1 |
large | proteins | 1 |
large | samples | 1 |
larger | donor | 1 |
larger | group | 1 |
larger | response | 1 |
important | transfusion | 1 |
larger | results | 1 |
larger | treatment | 1 |
largest | blood | 1 |
largest | case | 1 |
largest | group | 1 |
largest | hepatitis | 1 |
low | activities | 1 |
low | cell | 1 |
low | hepatitis | 1 |
important | virus | 1 |
important | studies | 1 |
higher | disease | 1 |
human | case | 1 |
higher | effects | 1 |
higher | protein | 1 |
higher | responses | 1 |
higher | sample | 1 |
higher | virus | 1 |
highest | blood | 1 |
highest | rna | 1 |
highest | time | 1 |
human | c | 1 |
immune | activity | 1 |
important | level | 1 |
immune | donors | 1 |
immune | protein | 1 |
immune | proteins | 1 |
immune | responsing | 1 |
important | cells | 1 |
important | day | 1 |
important | effect | 1 |
important | groups | 1 |
important | hcv | 1 |
viral | transfusion | 1 |